Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have been given a consensus recommendation of “Hold” by the fourteen analysts that are covering the company, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $14.0417.

Several research firms have commented on ARDT. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. UBS Group boosted their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a report on Thursday, May 7th. Royal Bank Of Canada lowered their target price on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Thursday, July 9th. Finally, Truist Financial dropped their target price on Ardent Health from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Tuesday, July 14th.

Insider Buying and Selling

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the transaction, the chief financial officer owned 329,183 shares in the company, valued at approximately $2,900,102.23. This trade represents a 3.13% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

Several institutional investors have recently made changes to their positions in ARDT. Caitong International Asset Management Co. Ltd boosted its holdings in Ardent Health by 1,177.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after buying an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Ardent Health in the third quarter valued at $61,000. New York State Common Retirement Fund increased its holdings in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after buying an additional 3,400 shares in the last quarter. Monetary Solutions Ltd acquired a new position in shares of Ardent Health in the fourth quarter worth about $79,000. Finally, Abel Hall LLC acquired a new position in shares of Ardent Health in the first quarter worth about $87,000.

Ardent Health Price Performance

Shares of ARDT opened at $10.13 on Monday. The firm has a market capitalization of $1.45 billion, a PE ratio of 10.67, a price-to-earnings-growth ratio of 2.39 and a beta of 0.76. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The company’s fifty day moving average price is $9.62 and its 200-day moving average price is $9.29.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, equities research analysts predict that Ardent Health will post 1.06 EPS for the current year.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.